2015 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.

 
 

News

 

Lombard Acquires Low-Profile EVAR Device Developer Altura Medical

July 30, 2015 -- Lombard Medical has announced the acquisition of Altura Medical, the Silicon Valley-based manufacturer of a low-profile endovascular stent graft system for tr…

Enrollment Completed in ILLUMENATE Pivotal Study of Spectranetics’ Stellarex DCB

July 29, 2015 -- Spectranetics Corporation announced that it has completed enrollment of 300 patients in the ILLUMENATE pivotal clinical study of the Stellarex drug-coated bal…

Emba Medical’s Hourglass Peripheral Embolization Plug Approved in Europe

July 29, 2015 -- Emba Medical Limited announced that the company has received CE Mark certification for its Hourglass peripheral embolization plug, which the company will begi…

Codman Neuro Launches Coils for Treatment of Intracranial Aneurysms

July 27, 2015 -- Codman Neuro, part of DePuy Synthes Companies of Johnson & Johnson, announced the introduction of a new platform of embolic coils for the treatment of bra…

European Studies Begin for Essential Medical’s Manta Large-Bore Vascular Closure Device

July 27, 2015 -- Essential Medical, Inc. announced that it has commenced European clinical studies using its Manta large-bore vascular closure device, which is designed to sea…

European Data Supporting Penumbra’s Ace64 Thrombectomy System Presented at SNIS

July 28, 2015 -- Penumbra, Inc. announced that results of a European multicenter study of the company’s Ace64 thrombectomy system were revealed in the abstract presentat…

Senate Bill Seeks to Streamline Regulatory Approval Process for Combination Medical Products

July 28, 2015 -- United States Sen. Johnny Isakson (R-Georgia) announced a bipartisan bill, Combination Product Regulatory Fairness Act of 2015 (S. 1767), that seeks…

Click here for more News coverage

Current Supplement

Sponsored by Endologix, Inc.

New Perspectives on Challenging AAA Necks

And why graft design matters in treating Reverse Taper Necks

physician counsel

Open Payments Update: Will More Data + More Errors = More Physician Peril?

An early look at samples from the full 2014 Open Payments records suggests that physicians must be ready to review and dispute their records before they go public.

Invention and Intellectual Property

Protecting Your Inventions, From Idea to Marketplace

The first step in bringing your medical device to market is to understand who owns the rights to your invention.

Beginning the Patent Process

The second step in bringing your medical device to market is to understand whether you can protect your invention.

Evaluating Freedom to Operate

The third step in bringing your medical device to market is to understand whether you can practice your invention.

Featured Center

 

Embolization

advertisement

 
Vascular Market Price  Change
Abbott Laboratories $50.69  0.00%
AstraZeneca PLC $33.79  0.00%
Boston Scientific Corporation $17.34  0.00%
BTG plc $654.00  0.00%
Cardiovascular Systems Inc. $29.84  0.00%
CR Bard Inc. $196.65  0.00%
Edwards Lifesciences Corp. $152.16  0.00%
Endologix Inc. $14.26  0.00%
Hansen Medical, Inc. $0.85  0.00%
Vascular Market Price  Change
Johnson and Johnson $100.21  0.00%
Lombard Medical, Inc. $4.09  0.00%
Medtronic, Inc. $78.39  0.00%
Merit Medical Systems, Inc. $25.56  0.00%
St. Jude Medical Inc. $73.82  0.00%
The Medicines Company $31.39  0.00%
The Spectranetics Corporation $17.10  0.00%
TriVascular Technologies, Inc. $6.36  0.00%
Vascular Solutions Inc. $37.23  0.00%

@EVToday

Stay current: Follow Endovascular Today on Twitter @EVToday

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.

Website Design by Sides Media